Chemotherapy for older patients with prostate cancer.
نویسندگان
چکیده
John Anderson, Hein Van Poppel*, Joaquim Bellmunt†, Kurt Miller‡, Jean-Pierre Droz§ and John M. Fitzpatrick¶ Department of Urology, Royal Hallamshire Hospital, Sheffield, UK, *Department of Urology, University Hospital KU Leuven, Belgium, †Department of Medical Oncology, University Hospital del Mar, Barcelona, Spain, ‡Department of Urology, University Hospital Benjamin Franklin Charité, Berlin, Germany, §Department of Medical Oncology, Centre Léon-Bérard, Lyon, France and ¶Department of Urology, Mater Misericordiae Hospital and University College Dublin, Ireland
منابع مشابه
Neoadjuvant chemotherapy in high-risk localized prostate cancer: a systematic review
Background: The rate of recurrence and mortality in high-risk prostate cancer remains high. On the other hand, the use of chemotherapy in metastatic prostate cancer has improved overall survival of patients. The aim of this study was to evaluate the effect of neoadjuvant chemotherapy alone on increasing survival of patients with high risk localized prostate cancer Methods: This is a systematic...
متن کامل“How should we treat older patients with Metastatic Colorectal Cancer, A Review”
Nearly 50 % of newly diagnosed colorectal cancer, affect people over 70 years of age. Inclusion of older patients in clinical trials has been extremely rare. As a result, there is debate on how to manage these patients because it is still unclear how to balance the therapeutic advantages and toxicities. For patients who do not have comorbid conditions, with performance status (P.S.) 0–1, treatm...
متن کاملClinical and Pathological Features of Iraqi Patients with Prostate Cancer
Background: The clinical pathological features were detected by measuring the prostatic acid phosphatase (PAP) activity according to the stages and grades of prostate cancer. We also explored the relationship between the disease and age with family history among the patients. Methods: Data were collected from direct interview and from the patient’s records. Blood samples that collected before ...
متن کاملKnockdown of HSF1 sensitizes resistant prostate cancer cell line to chemotherapy
The treatment of prostate cancer patients usually starts with androgen ablation and followed by chemotherapy; however, in some cases the tumor develops resistant phenotype. Combination therapy is currently regarded as a cornerstone in cancer therapy to overcome the drug resistance. Herein, we investigated the combinatory effect of Docetaxel and Trastuzumab with a novel nanomedicine, BCc1. Also,...
متن کاملComparison of PSA profile with positive prostate cancer pathology and Gleason scores in 2015-2017 in Hamadan
Background and Objective: Prostate cancer is one of the most common cancers of the urinary system. The most used method for diagnosis is transrectal ultrasonography-guided biopsy. The purpose of this study is a statistical analysis with the aim of reducing unnecessary biopsies based on individual, geographical and genetic patterns in our region. Methods: The medical records of all patients who...
متن کاملProstate Cancer Screening in Middle-Aged and Older American Men: Combined Effects of Ethnicity and Years of Schooling
Background: Prostate cancer screening is more commonly utilized by highly educated people. As shown by marginalization-related diminished returns (MDRs), the effects of socioeconomic status (SES) such as education on the health outcomes are considerably smaller for ethnic minorities than for Whites. The role of MDRs as a source of ethnic health disparities is, however, still un...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BJU international
دوره 99 2 شماره
صفحات -
تاریخ انتشار 2007